# The Biomarker Paradox at the Heart of Qilu's CLDN6 ADC - Date: 2026-04-23 - Category: Biotech & Life Sciences A drug designed to hit a biomarker works in patients who lack that biomarker. Qilu's investigators have an explanation. It may not hold. ---